Expert Rev Ophthalmol. 2008;3(3):311-323. Choroidal neovascularization in PM has been treated with different approaches, which include laser photocoagulation, submacular surgery, photodynamic therapy ...

Cataract surgery in the highly myopic patient, typically defined by an axial length greater than 26 mm, represents one of the ...

Co announces positive results from its Phase II Combretastatin A4 Phosphate clinical trial in myopic macular degeneration. The primary efficacy endpoint of the study was maintenance of visual acuity ...

Children and adolescents were at higher risk for myopic maculopathy progression if they had worse best-corrected visual acuity and longer axial length, among other risk factors. Myopic maculopathy ...

Impact Biotech Ltd. has entered into an agreement with Maastricht University to collaborate on research focused on eye treatment to arrest the progression of pathological myopia, also known as myopic ...

University of Houston College of Optometry professor is co-leading a national $25 million NIH-funded clinical trial to delay the development of myopia. Researchers are testing whether low-concentrate ...

Myopic maculopathy, also known as myopic macular degeneration, is a key feature of pathologic myopia. In the META-PM classification system, myopic maculopathy lesions are categorized into five ...

The short-term use of atropine eye drops to treat myopia in children did not affect long-term visual outcomes, the prospective observational ATLAS study of participants from two randomized trials ...

Expert Rev Ophthalmol. 2008;3(3):311-323. The new and promising strategies for treating CNV include the use of drugs against VEGF, in particular isoform A, which is the most potent promoter of ...